Insights

Innovative AI Platform Owkin offers a cutting-edge AI-powered platform focused on revolutionizing biomedical research and drug discovery, presenting an opportunity to partner with pharmaceutical and biotech companies seeking advanced biological data analysis and rejuvenation therapies.

Strong Industry Collaborations With partnerships and real-world data from 80 of the top 100 global hospitals, Owkin demonstrates extensive clinical data access, which could be leveraged to enhance drug development pipelines and clinical trial efficiency for healthcare organizations.

Rapid Product Expansion Recent launches of K Pro and K1.0 showcase Owkin’s commitment to expanding its AI research modules; this growth indicates opportunities to integrate these solutions into enterprise R&D workflows and accelerate medical research initiatives.

Funding and Market Position With an interim revenue estimate of $50M to $100M and $50M in funding, Owkin is positioned as a financially promising partner capable of scaling collaborative projects with biotech and pharmaceutical firms seeking innovative biological insights.

Leadership and Talent Led by top talent from industry giants such as Google Brain and DeepMind, Owkin offers access to a highly skilled team capable of delivering specialized AI solutions, making it an attractive partner for organizations needing expertise in AI-driven biomedical research.

Owkin Tech Stack

Owkin uses 8 technology products and services including CUDA, git, Asana, and more. Explore Owkin's tech stack below.

  • CUDA
    Audio, Video, Graphics
  • git
    Development
  • Asana
    Issue Trackers
  • Vue.js
    Javascript Frameworks
  • Yoast SEO
    Search Engines
  • Jaeger
    System Analytics & Monitoring
  • Navan
    Travel And Expense Management
  • HTTP/3
    Web & Portal Technology

Media & News

Owkin's Email Address Formats

Owkin uses at least 1 format(s):
Owkin Email FormatsExamplePercentage
First.Last@owkin.comJohn.Doe@owkin.com
99%
First.Middle@owkin.comJohn.Michael@owkin.com
1%

Frequently Asked Questions

Where is Owkin's headquarters located?

Minus sign iconPlus sign icon
Owkin's main headquarters is located at 831 Broadway, Unit 3R New York, NY 10003, US. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Owkin's official website and social media links?

Minus sign iconPlus sign icon
Owkin's official website is owkin.com and has social profiles on LinkedInCrunchbase.

What is Owkin's NAICS code?

Minus sign iconPlus sign icon
Owkin's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Owkin have currently?

Minus sign iconPlus sign icon
As of October 2025, Owkin has approximately 467 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Business Development Officer: J. P.Chief Marketing Officer: D. M.Chief People Officer: M. O.. Explore Owkin's employee directory with LeadIQ.

What industry does Owkin belong to?

Minus sign iconPlus sign icon
Owkin operates in the Technology, Information and Internet industry.

What technology does Owkin use?

Minus sign iconPlus sign icon
Owkin's tech stack includes CUDAgitAsanaVue.jsYoast SEOJaegerNavanHTTP/3.

What is Owkin's email format?

Minus sign iconPlus sign icon
Owkin's email format typically follows the pattern of First.Last@owkin.com. Find more Owkin email formats with LeadIQ.

How much funding has Owkin raised to date?

Minus sign iconPlus sign icon
As of October 2025, Owkin has raised $655M in funding. The last funding round occurred on Nov 18, 2021 for $414M.

When was Owkin founded?

Minus sign iconPlus sign icon
Owkin was founded in 2016.
Owkin

Owkin

Technology, Information and InternetUnited States201-500 Employees

Chemistry is no longer the biggest challenge in medicine — biology is, and it remains vastly more complex, dynamic, and poorly understood.
The key to unlocking it is understanding and reversing biological aging, especially of the immune system, which drives most major diseases.
OWKIN K is the first universal biology copilot, built on reinforcement learning and patient data from 80 of the world’s 100 largest hospitals, designed to discover, validate, and deploy rejuvenation-based interventions across pharma, CROs, biotechs, VCs, and LLM platforms.
Led by top talent from Google Brain, Novartis, and DeepMind, OWKIN combines deep scientific credibility with a scalable SaaS + equity model tied to real-world clinical and commercial impact.
We’re not building a tool — we’re building the operating system for the future of biology and medicine.

Section iconCompany Overview

Headquarters
831 Broadway, Unit 3R New York, NY 10003, US
Website
owkin.com
NAICS Code
5415 - Computer Systems Design and Related Services
Founded
2016
Employees
201-500

Section iconFunding & Financials

  • $655M

    Owkin has raised a total of $655M of funding over 6 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $414Mas a equity funding.

  • $25M$50M

    Owkin's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $655M

    Owkin has raised a total of $655M of funding over 6 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $414Mas a equity funding.

  • $25M$50M

    Owkin's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.